Epistaxis - 27 Studies Found
Active, not recruiting |
: Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia :
: 2011-11-28 : Drug: Thalidomide Eligible patients will receive thalidomi |
Withdrawn |
: Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) :
: Drug: Ranibizumab Patients will be treated with a total of 4 applications of ranibizumab in a fine mist |
Recruiting |
: Intranasal Bevacizumab for HHT-Related Epistaxis :
|
Completed |
: Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) :
|
Recruiting |
: The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial. :
: 2014-11-05 :
|
RECRUITING |
: Nasal Compression Device Study for Epistaxis : Epistaxis Nosebleed : 2024-10-31 : Participants assigned to the NasaClip arm will not receive routine care as the objective of this study is to compare the NasaClip device to routine di |
RECRUITING |
: Cauterization of the Anterior Ethmoidal Artery by Transconjunctival Approach : Epistaxis, Anterior Ethmoid Artery : 2024-10-31 |